Key regulatory points for Epitalon Australia compliance: Epitalon is not approved by the Therapeutic Goods Administration (TGA) as a registered medicine for human or veterinary use It is classified strictly for laboratory and research purposes, not for human consumption Supply, import, and handling of research peptides fall under Australian regulatory oversight, and institutions should confirm current scheduling status directly through TGA resources before procurement Any research involving human subjects must comply with Research Ethics Committee approval and applicable Good Clinical Practice standards Marketing or supplying Epitalon with therapeutic claims, or implying suitability for human treatment, falls outside permitted research-use classifications Researchers and institutions should treat Epitalon strictly as a laboratory reagent, ensuring internal documentation, handling protocols, and communications consistently reflect its research-only status
Update on C1 esterase inhibitor in human solid organ transplantation
Given that these cytokines play a substantial role in leukocyte recruitment in AAA disease[30], we generated polymorphonuclear neutrophil-like cells (dPMN) in vitro by differentiating HL60 cells and performed co-culture studies (Fig
Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, et al
Week 3: I deliberately increased training volume to test if this was just recovery from backing off
